International WAGR Syndrome Association

11p Deletion Syndrome

Home

About IWSA

Annual Report 2010

IWSA Past Present Future

Contact Us >

Discussion Group

IWSA & United Way

IWSA on YOU TUBE

ALL Stars

Donate Now>

How can you help ?

Newsletters/Mailing list

Online News

WAGR Weekend Events

WAGR Weekend Assistance

2011 Weekend Sponsors

2010 Weekend Sponsors

NEWLY DIAGNOSED ?

Coping with Dx & Dr's

FAQ's

FAQ's Espanol

"Our Story"

Checklist for parents

Information Packet

Guide for Physicians

Articles of interest

Education/School

LendingLibrary Guidelines

Nephrology Q & A

NEWS! Latest from NIH

NIH RESEARCH ENROLLMENT

NIH - Our Visit

NIH - My Experience

Pancreatitis in WAGR

Renal Disease in WAGR

RESEARCH at NIH

Seizures/Epilespy

Sensory Issues

Short Stature in WAGR

Wilms Tumor Study Group

Resource Links

Int'l Rare Disease Links

WAGR Angels

New! Site Map

 
BDNF Haploinsufficiency in Patients with WAGR Syndrome
Is Associated with Decreased Behavioral Responses to Pain



Rebecca L. Levinn, Jack W. Tsao, Diane C. Adler-Wailes, Chanelle A. Wijesinghe, Kyra S. Jefferson-George, Owen M. Rennert, Jack A. Yanovski, Joan C. Han. Unit on Growth and Obesity, PDEGEN, NICHD, National Institutes of Health, Bethesda, MD; Department of Neurology, Uniformed Services University of the Health Sciences, Bethesda, MD.


BACKGROUND: WAGR syndrome (Wilms tumor, Aniridia, Genitourinary abnormalities, and mental Retardation) is caused by heterozygous contiguous gene deletions of variable size on Chromosome 11. The gene that encodes brain-derived neurotrophic factor (BDNF) is included in the region of deletion in about half of WAGR patients. In animal studies, BDNF appears to play a role in modulating nociceptive sensory inputs. No quantitative data exist relating pain perception to BDNF haploinsufficiency in humans.

OBJECTIVE: To study patients with WAGR syndrome to determine if parent-reported behavioral responses to pain differ among those with and without BDNF haploinsufficiency.


DESIGN/METHODS: Comparative genomic hybridization was performed for 31 subjects with WAGR syndrome (age 13.98.3y) to establish if one copy of the BDNF gene was deleted. Parents completed the Non-Communicating Childrens Pain Checklist-Revised (NCCPC-R), which assesses occurrence of behavioral responses (subscales: vocal, social, facial, physical activity, body and limb, physiological, and eating/sleeping) to injuries and illnesses considered painful to most people. Scores for subjects with and without BDNF haploinsufficiency were compared using the Mann-Whitney U test.


RESULTS: 58% of subjects had BDNF haploinsufficiency (BDNF+/-). Compared to those with both BDNF alleles intact (BDNF+/+), BDNF+/- subjects had lower mean NCCPC-R total response scores (BDNF+/- vs. BDNF+/+: 22.815.9 vs. 35.417.0, p=0.031), as well as lower NCCPC-R subscores for vocal (p=0.010), facial (p=0.043), body and limb (p=0.033), and physiological (p=0.044) responses (primarily subscales that reflect perception of pain intensity). No statistically significant differences were observed for social, physical activity, and eating/sleeping responses (subscales previously found not to be correlated with pain intensity).


CONCLUSIONS: Among individuals with WAGR syndrome, BDNF haploinsufficiency is associated with fewer behavioral responses to typically painful stimuli. These data support a role for BDNF in human nociception.


First Author is a Student
E-PAS2008:634504.8


Winning Attitudes, Great Rewards

Web Hosting powered by Network Solutions®